BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10151780)

  • 1. Some IDSs, PHOs should follow insurance regs, NAIC recommends.
    Healthc Syst Strategy Rep; 1995 Sep; 12(18):5-6. PubMed ID: 10151780
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating payer and provider risk through capitation.
    Barth SM
    Manag Care Q; 1997; 5(1):19-24. PubMed ID: 10164645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Storm warning. Insurance regulation.
    Health Syst Rev; 1995; 28(5):26-9, 32-7. PubMed ID: 10152467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
    Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitrust and the developing continuum: advice for administrators, managers, and providers.
    Garrison P
    Continuum; 1998; 18(1):1, 3-6. PubMed ID: 10178903
    [No Abstract]   [Full Text] [Related]  

  • 6. California debate brewing over full risk capitation contracts.
    Pulley M
    Integr Healthc Rep; 1994 Jan; ():14-5. PubMed ID: 10132216
    [No Abstract]   [Full Text] [Related]  

  • 7. State insurance regulation of provider-sponsored organizations.
    Kelly MP
    Healthc Financ Manage; 1997 Jul; 51(7):44-6. PubMed ID: 10168437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing risk-sharing mechanisms.
    Clark CS
    Healthc Financ Manage; 1996 Apr; 50(4):20-1. PubMed ID: 10156593
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for integrated delivery systems.
    Guttler SD
    N Engl J Med; 2010 Jan; 362(1):86; author reply 86. PubMed ID: 20054055
    [No Abstract]   [Full Text] [Related]  

  • 10. Reasons providers form PHOs.
    Abbey FB; Treash KM
    Healthc Financ Manage; 1995 Aug; 49(8):38-40, 42, 44 passim. PubMed ID: 10144172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkmate. Docs are pawns in game of creating integrated systems.
    Greene J
    Mod Healthc; 1997 Mar; 27(9):74, 76, 78-80. PubMed ID: 10165075
    [No Abstract]   [Full Text] [Related]  

  • 12. A primer on PHO capitation contracts.
    Hillman DC
    J Health Hosp Law; 1996 Dec; 29(5):288-306. PubMed ID: 10164236
    [No Abstract]   [Full Text] [Related]  

  • 13. Life after PHOs: MSOs take center stage.
    Goldstein D
    Med Interface; 1995 Sep; 8(9):59-65. PubMed ID: 10151604
    [No Abstract]   [Full Text] [Related]  

  • 14. Ohio weighs rules for risk bearers.
    Jaklevic MC
    Mod Healthc; 1996 Apr; 26(16):26. PubMed ID: 10156896
    [No Abstract]   [Full Text] [Related]  

  • 15. EDI helps IPAs, PHOs manage risk.
    Hand SM
    Healthc Financ Manage; 1999 Feb; 53(2):78-9, 81. PubMed ID: 10345623
    [No Abstract]   [Full Text] [Related]  

  • 16. Integration options.
    Williams L
    J Health Hosp Law; 1996; 29(2):88-96, 106. PubMed ID: 10160177
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolving conflicting laws and policy in integrated delivery systems development.
    Shaffer AD; Pavarini PA
    J Law Health; 1997-1998; 12(1):85-120. PubMed ID: 10182031
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk-sharing PHOs escaping state regulators' scrutiny, study says.
    Healthc Syst Strategy Rep; 1995 Aug; 12(17):9-11. PubMed ID: 10152380
    [No Abstract]   [Full Text] [Related]  

  • 19. IRS views on physician control of integrated networks.
    Griffith GM
    Healthc Financ Manage; 1995 Nov; 49(11):30-2, 34, 36. PubMed ID: 10151865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.